DexCom (Germany) Market Value
| DC4 Stock | EUR 72.14 0.11 0.15% |
| Symbol | DexCom |
DexCom 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DexCom's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DexCom.
| 04/21/2025 |
| 07/20/2025 |
If you would invest 0.00 in DexCom on April 21, 2025 and sell it all today you would earn a total of 0.00 from holding DexCom Inc or generate 0.0% return on investment in DexCom over 90 days. DexCom is related to or competes with WuXi AppTec, Thermo Fisher, Danaher, Siemens Healthineers, Agilent Technologies, IDEXX Laboratories, and IQVIA Holdings. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose ... More
DexCom Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DexCom's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DexCom Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.07 | |||
| Information Ratio | 0.0691 | |||
| Maximum Drawdown | 19.15 | |||
| Value At Risk | (3.45) | |||
| Potential Upside | 3.92 |
DexCom Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DexCom's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DexCom's standard deviation. In reality, there are many statistical measures that can use DexCom historical prices to predict the future DexCom's volatility.| Risk Adjusted Performance | 0.1162 | |||
| Jensen Alpha | 0.299 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.098 | |||
| Treynor Ratio | 1.26 |
DexCom Inc Backtested Returns
DexCom appears to be very steady, given 3 months investment horizon. DexCom Inc secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12 % return per unit of risk over the last 3 months. We have found thirty technical indicators for DexCom Inc, which you can use to evaluate the volatility of the firm. Please utilize DexCom's Coefficient Of Variation of 853.49, mean deviation of 1.85, and Downside Deviation of 2.07 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, DexCom holds a performance score of 9. The firm shows a Beta (market volatility) of 0.26, which means not very significant fluctuations relative to the market. As returns on the market increase, DexCom's returns are expected to increase less than the market. However, during the bear market, the loss of holding DexCom is expected to be smaller as well. Please check DexCom's value at risk, downside variance, and the relationship between the maximum drawdown and potential upside , to make a quick decision on whether DexCom's price patterns will revert.
Auto-correlation | -0.47 |
Modest reverse predictability
DexCom Inc has modest reverse predictability. Overlapping area represents the amount of predictability between DexCom time series from 21st of April 2025 to 5th of June 2025 and 5th of June 2025 to 20th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DexCom Inc price movement. The serial correlation of -0.47 indicates that about 47.0% of current DexCom price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.47 | |
| Spearman Rank Test | 0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 3.27 |
DexCom Inc lagged returns against current returns
Autocorrelation, which is DexCom stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting DexCom's stock expected returns. We can calculate the autocorrelation of DexCom returns to help us make a trade decision. For example, suppose you find that DexCom has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
DexCom regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If DexCom stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if DexCom stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in DexCom stock over time.
Current vs Lagged Prices |
| Timeline |
DexCom Lagged Returns
When evaluating DexCom's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of DexCom stock have on its future price. DexCom autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, DexCom autocorrelation shows the relationship between DexCom stock current value and its past values and can show if there is a momentum factor associated with investing in DexCom Inc.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in DexCom Stock
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:Check out DexCom Correlation, DexCom Volatility and DexCom Alpha and Beta module to complement your research on DexCom. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
DexCom technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.